Print

Generics Firms Could Pay €20 Million a Year for Pharmacovigilance, EGA - European Generic Medicines Association Says  
9/25/2012 8:21:42 AM

Proposed EMA pharmacovigilance fees are too high and place a disproportionate burden on generics firms according to the European Generic Medicines Association (EGA).
//-->